DJ Biogen Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ slipped 2.40% to $202.95 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.70% to 7,489.72 and the Dow Jones Industrial Average rising 0.53% to 52,485.03.
This was the stock's second consecutive day of losses.
Biogen Inc. closed 7.63% short of its 52-week high of $219.72, which the company achieved on June 29th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ rose 0.21% to $256.35, Pfizer Inc. $(PFE)$ rose 0.40% to $25.01, and AbbVie Inc. $(ABBV)$ fell 2.51% to $250.94.
Data source: Dow Jones Market Data, FactSet. Data compiled July 31, 2026.
Comments